ロード中...
Safety of Spironolactone Use in Ambulatory Heart Failure Patients
BACKGROUND: Since the Randomized Aldactone Evaluation Study (RALES), the use of spironolactone is recommended in systolic heart failure (HF) patients that have been in New York Heart Association (NYHA) class III or IV. There is limited information on the use, side effects, and withdrawal rate of spi...
保存先:
| 出版年: | Clin Cardiol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wiley Periodicals, Inc.
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6652974/ https://ncbi.nlm.nih.gov/pubmed/19006114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.20284 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|